{"nct_id":"NCT06960577","title":"Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-05-15","start_date_type":"ACTUAL","primary_completion_date":"2028-10-31","primary_completion_date_type":"ESTIMATED","completion_date":"2028-10-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}